Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 37Urinary Bladder Neoplasms 12Breast Neoplasms 7Neoplasms 6Kidney Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma 5Carcinoma, Transitional Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Heart Failure 3Disease 3Colorectal Neoplasms 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Pulmonary Disease, Chronic Obstructive 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Failure, Chronic 2Kidney Diseases 2Hematologic Neoplasms 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Asthma 2von Hippel-Lindau Disease 1the Detection of Prostate Cancer in Men 1Uterine Cervical Neoplasms 1

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Castration-Resistant Prostate Cancer (CRPC) × Genitourinary × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡